These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9193586)

  • 1. Role of in situ IL-2r and TGF-beta expression in tolerant vascularized bone marrow (limb) transplant chimeras.
    Tatem LD; Hirpara S; Dalsey RM; Iannacone WM; DeLong WG; Hewitt CW
    Transplant Proc; 1997 Jun; 29(4):2194-5. PubMed ID: 9193586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of alloimmune tolerance associated with mixed chimerism induced by vascularized bone marrow transplants.
    Ramsamooj R; Llull R; Patel MP; Beko KR; Black KS; Hewitt CW
    Cell Transplant; 2002; 11(7):683-93. PubMed ID: 12518895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-host disease in limb transplantation: digital image analysis of bone marrow and TGF-beta expression in situ using a novel 3-D microscope.
    Ramsamooj R; Llull R; Tatem LD; Black KS; Lotano V; Dalsey RM; Born CT; DeLong WG; Hewitt CW
    Transplant Proc; 1996 Aug; 28(4):2029-31. PubMed ID: 8769145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular mechanisms of alloimmune non-responsiveness in tolerant mixed lymphocyte chimeras induced by vascularized bone marrow transplants.
    Llull R; Ramsamooj R; Black KS; Hewitt CW
    Transpl Int; 1994; 7 Suppl 1():S453-6. PubMed ID: 11271279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat renal allograft tolerance is associated with local TGF-beta and absence of IL-2r expression within chimeric immunocytic foci.
    Hewitt CW; Strande L; Santos M; Goodman M; Tarnoff M; Zaontz MR; DelRossi AJ; Doolin EJ
    Transplant Proc; 1997 Jun; 29(4):2183-4. PubMed ID: 9193580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts.
    Hewitt CW; Ramsamooj R; Patel MP; Yazdi B; Achauer BM; Black KS
    Transplantation; 1990 Nov; 50(5):766-72. PubMed ID: 2238052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-versus-host disease in extremity transplantation: digital image analysis of bone marrow in situ.
    Hewitt CW; Englesbe MJ; Tatem LD; Strande LF; Doolin EJ; Dalsey RM; DeLong WG
    Ann Plast Surg; 1995 Jul; 35(1):108-12. PubMed ID: 7574277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascularized bone marrow transplantation (VBMT): induction of stable mixed T-cell chimerism and transplantation tolerance in unmodified recipients.
    Yazdi B; Patel MP; Ramsamooj R; Llull R; Achauer BM; Black KS; Hewitt CW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):739-40. PubMed ID: 1990672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Nov; 178(1):487-93. PubMed ID: 22484382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascularized bone marrow transplantation in rats: evidence for amplification of hematolymphoid chimerism and freedom from graft-versus-host reaction.
    Llull R; Murase N; Ye Q; Manez R; Demetris AJ; Fournier V; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):164-5. PubMed ID: 7878956
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo administration of interleukin-6 in murine allogeneic bone marrow chimeras: early and delayed enhancement of hematopoiesis accompanied with split tolerance but not with graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Tanaka J; Imai K; Han M; Fujii Y; Kobayashi M; Higa T; Kasai M
    Immunobiology; 1994 Jun; 190(4-5):346-67. PubMed ID: 7982720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of graft-versus-host disease in the isolated vascularized bone marrow transplant.
    Tai CY; Strande LF; Eydelman R; Sheng X; VanTran JL; Matthews MS; Hewitt CW
    Transplantation; 2004 Jan; 77(2):316-9. PubMed ID: 14743002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microchimerism following allogeneic vascularized bone marrow transplantation--its possible role in induction of posttransplantation tolerance.
    Durlik M; Lukomska B; Ziółkowska H; Namysłowski A; Janczewska S; Cybulska E; Olszewski WL
    Ann Transplant; 1998; 3(1):24-6. PubMed ID: 9869894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Critical Role for TGF-β/Fc and Nonlytic IL-2/Fc Fusion Proteins in Promoting Chimerism and Donor-Specific Tolerance.
    Xu H; Zheng XX; Zhang W; Huang Y; Ildstad ST
    Transplantation; 2017 Feb; 101(2):294-301. PubMed ID: 27306533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of vascularized bone marrow transplantation: current status and future clinical applications.
    Gordon CR; Tai CY; Suzuki H; Strande LF; Ramsamooj R; Matthews MS; Black KS; Hewitt CW
    Microsurgery; 2007; 27(4):348-53. PubMed ID: 17477415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
    Foster RD; Ascher NL; McCalmont TH; Neipp M; Anthony JP; Mathes SJ
    Transplantation; 2001 Sep; 72(5):791-7. PubMed ID: 11571439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.